New isoniazid/ethionamide resistance gene mutation and screening for multidrug- resistant Mycobacterium tuberculosis strains

The Lancet

Volumn 346, Issue 8973, 1995, Pages 502-503

  Ristow, Michael ^a,b   Möhlig, Matthias ^b   Rifai, Mohammed ^b   Schatz, Helmut ^b   Feldmann, Knut ^b   Pfeiffer, Andreas ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Asklepios Clinics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHIONAMIDE; ISONIAZID; TUBERCULOSTATIC AGENT;

CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; TUBERCULOSIS;

EID: 0029121093     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91351-3     Document Type: Letter

References (4)

1. The new tuberculosis
2. InhA, a gene encoding a target for isoniazide and ethionamide in M tuberculosis
3. Crystal structure and function of the isoniazid target of M tuberculosis
4. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study